Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention von Francey, S.M, Nelson, B, Thompson, A, Parker, A.G, Kerr, M, Macneil, C, Fraser, R, Hughes, F, Crisp, K, Harrigan, S, Wood, S.J, Berk, M, McGorry, P.D

Volltext

Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample von Burkhardt, E., Berger, M., Yolken, R.H., Lin, A., Yuen, H.P., Wood, S.J., Francey, S.M., Thompson, A., McGorry, P.D., Nelson, B., Yung, A.R., Amminger, G.P.

Volltext

Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals von Amminger, G.P., Leicester, S., Yung, A.R., Phillips, L.J., Berger, G.E., Francey, S.M., Yuen, H.P., McGorry, P.D.

Volltext

0264 ASSESSING THOSE AT HIGH RISK OF PSYCHOTIC DISORDER USING THE COMPREHENSIVE ASSESSMENT OF AT RISK MENTAL STATES (CAARMS) von Nelson, B., Yung, A.R., Francey, S.M., McGorry, P.D.

Volltext

FC2B CO-MORBIDITY IN UHR CLIENTS: INTAKE AND 12-MONTH AXIS I DIAGNOSES von Francey, S.M., Nelson, B., Leicester, S., Phillips, L.J., Yung, A.R.

Volltext

WC1E BASIC SYMPTOMS IN THE UHR POPULATION AT THE PACE CLINIC von Nelson, B., Yung, A.R., Francey, S.M., Stanford, C., McGorry, P.D.

Volltext

0553 ASSESSING THOSE AT HIGH RISK OF PSYCHOTIC DISORDER –AN EXPERIENTIAL WORKSHOP USING THE COMPREHENSIVE ASSESSMENT OF AT RISK MENTAL STATES (CAARMS) von Yung, A.R., O'Dwyer, L.E., Francey, S.M., Simmons, M.B., Nelson, B.

Volltext

0260 CO-MORBID BORDERLINE PERSONALITY DISORDER AND FIRST EPISODE PSYCHOSIS: HOW MANY AND WHAT HAPPENS? von Francey, S.M., Jovev, M., Phassouliotis, C., McDougall, E., Cotton, S., Chanen, A.

Volltext

TC3C GENERALISED AND SPECIFIC COGNITIVE VULNERABILITY MARKERS FOR PSYCHOSIS: LATEST FINDINGS FROM AN ULTRA HIGH RISK COHORT von Brewer, W.J., Wood, S.J., Phillips, L.J., Francey, S.M., Pantelis, C., Yung, A.R., McGorry, P.D.

Volltext

0536 SERUM ANTIBODIES AGAINST TOXOPLASMA GONDII ARE ASSOCIATED WITH MORE POSITIVE SYMPTOMS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS von Amminger, G.P., McGorry, P.D., Berger, G.E., Yung, A.R., Phillips, L.P., Harrigan, S.M., Wade, D., Francey, S.M., Yolken, R.H.

Volltext